Adherence to international guidelines for the management ofHelicobacter pyloriinfection among gastroenterologists and gastroenterology fellows in Italy: A Survey of the Italian Federation of Digestive Diseases ‐ FISMAD
Open Access
- 11 November 2021
- journal article
- research article
- Published by Wiley in Helicobacter
- Vol. 27 (1) , e12862
Abstract
Background: Information on the management ofHelicobacter (H.) pyloriinfection by gastroenterologists and gastroenterology fellows are scarce. We aimed to assess practice of gastroenterologists and gastroenterology fellows and their adherence to guidelines for diagnosis and treatment ofH. pyloriinfection in Italy.Materials and Methods: All gastroenterologists and gastroenterology fellows attending the National Congress of Digestive Diseases ‐ FISMAD were invited to fill‐in an on‐line questionnaire. The questionnaire included questions on the diagnosis and treatment ofH. pyloriinfection.Results: A total of 279 gastroenterologists and 61 gastroenterology fellows participated to the study. The13C‐urea breath test was the most preferred method among gastroenterologists and fellows for the diagnosis ofH. pyloriinfection (40.4% and 57.6%, respectively) and the confirmation of eradication (61.3% and 70%, respectively). Sequential therapy was the most preferred first‐line treatment ofH. pylorifor both gastroenterologists and gastroenterology fellows (31.8% and 44%, respectively), followed by bismuth quadruple therapy (31% and 27.6%, respectively) and clarithromycin triple therapy (26.8% and 22.4%, respectively). Only 30% of gastroenterologists and 38.5% of fellows used the clarithromycin triple therapy for the recommended duration of 14 days. Bismuth quadruple therapy was the most preferred second‐line therapy for both gastroenterologists and fellows. The majority of gastroenterologists and fellows would prefer an empirical therapy at third line (72.6% and 62.5%, respectively) and a susceptibility‐guided therapy at fourth line (46.7% and 71.4%, respectively).Conclusions: Practices of gastroenterologists and gastroenterology fellows are in line with guidelines’ recommendations, apart for the first‐line treatment ofH. pyloriinfection. Targeted educational interventions to improve adherence to guidelines are needed.Keywords
This publication has 38 references indexed in Scilit:
- Randomized clinical trial comparing ten day concomitant and sequential therapies for Helicobacter pylori eradication in a high clarithromycin resistance areaEuropean Journal of Internal Medicine, 2016
- The Toronto Consensus for the Treatment of Helicobacter pylori Infection in AdultsGastroenterology, 2016
- [How do gastroenterologists in Peru deal with Helicobacter pylori infection? Study based on a survey conducted in 2014].2016
- Review article: the global emergence ofHelicobacter pyloriantibiotic resistanceAlimentary Pharmacology & Therapeutics, 2015
- Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015Digestive and Liver Disease, 2015
- Kyoto global consensus report onHelicobacter pylorigastritisGut, 2015
- Optimum duration of regimens for Helicobacter pylori eradicationCochrane Database of Systematic Reviews, 2013
- Is Helicobacter pylori antibiotic resistance surveillance needed and how can it be delivered?Alimentary Pharmacology & Therapeutics, 2012
- Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of Helicobacter pyloriClinical Gastroenterology and Hepatology, 2003
- Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluationsThe Lancet, 1993